CLINICAL ROLE -
July 23rd 2025
June 18th 2025
Lenacapavir becomes the first and only twice-yearly option for HIV prevention.
March 20th 2025
As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.
March 17th 2025
Data from conference abstracts and presentations indicate that both preexposure prophylaxis methods continue to demonstrate efficacy.
January 9th 2025
Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
Improved Access to PrEP Needed for HIV Prevention in US Military Services
Despite universal access to care afforded to US military service members, there is a need to improve and expand access to PrEP for those patients at highest risk for HIV infection.
Read More
Are You Ready to Counsel on Pre-Exposure Prophylaxis?
When individuals who are at risk for HIV use PrEP, and use it appropriately, risk of infection is significantly lowered.
Pre-Exposure Prophylaxis for HIV: Is a Pill the New Condom?
Trending News Today: CVS Offers Pharmacists, Consumers Tool to Find Cheaper Drug Alternatives
Top news of the day from across the health care landscape.
Trending News Today: Most High-Risk Individuals Unaware of PrEP for HIV Prevention
HIV Prophylaxis with PrEP: Less May be More
Pre-exposure prophylaxis saves lives by reducing the risk of acquiring HIV, but the need for cost-saving is great.
Spotlight on 'Informal' HIV Prevention Efforts
Pre-exposure prophylaxis is highly effective preventing HIV if used as prescribed.
Preexposure Prophylaxis: Get the Word Out!
Oral preexposure prophylaxis (PrEP) has the potential to prevent HIV transmission and ultimately to help eradicate this devastating viral infection.
Pre-Exposure Prophylaxis Reduces HIV Risk Among Adolescent Males
Findings suggest daily use of Truvada is safe and effective among males aged 15 to 17 years.
More Patients With HIV Living in Remission
The degree of the success for HIV remission vary in different parts of the country.
Class-action Lawsuit: Aetna Faces Punishment for HIV Privacy Breach
Approximately 12,000 customers were affected by the breach.
FDA Approves Label Change for HIV Drug
Odefsey label updated to include updated data from clinical trials examining patients who switched from tenofovir disoproxil fumarate-based regimens.
Odefsey Receives Approved Label Change from FDA
Changes include additional trial data in virologically-suppressed adults with HIV-1 infection.
Treating Young HIV Patients Has Different Set of Challenges
Younger patients with HIV have competing needs that distract them from fully engaging in care.
Some HIV Patients With Low Viral Load Forgo Treatment
Prolonged delay in antiretroviral treatment among patients necessitate scrutinization of the current guidelines for HIV therapy.
Pre-Exposure Prophylaxis on as Needed Basis Found Safe for Men
Four doses of PrEP around the time of sexual activity reduced HIV-infection risk by 97%.
Pharmaceutical Care Improves Outcomes in Patients With HIV
Pharmacist intervention on drug-related problems in HIV outpatients can alleviate adherence issues.
Reported Cases of HIV-Infection Increases 140% in Philippines
Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.
HIV-Preventive Vaginal Ring Found Safe, Acceptable Among Adolescents
Scientists say ring containing pre-exposure prophylaxis and Truvada is safe in US teens, now need data in African adolescent girls.
Top 5 HIV Drugs in the Pipeline
Long-acting HIV medications could solve problems with adherence, reduce costly laboratory tests to monitor their efficacy, and bring down drug costs.
Walgreens Healthcare Clinics Prescribe Pre-Exposure Prophylaxis for HIV Prevention
PrEP has been found to be effective in preventing HIV in high-risk populations.
How to Improve Treatment of Comorbidities in HIV
Increasingly, individuals with HIV also have comorbid conditions, such as cardiovascular disease, hypertension, and diabetes.
Interactive Map Explores the HIV Epidemic Across the United States
New diagnoses and prevalence of HIV is illustrated by demographics, location, and social determinants of health.
President Trump Encourages Americans to Learn Their Status on National HIV Testing Day
More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.
Challenges Remain in Eliminating HIV
A number of hurdles in HIV, including preventative efforts, still need to be addressed.
Managing Drug Interactions in Patients With HIV
Screening for drug interactions is a challenge when a patient with HIV presents with several prescriptions.
Key Risk Factors in Stopping Spread of HIV
HIV clinical staff should ask questions about each patient’s relationships and sexual activity regularly and redundantly.
FDA Approves Generic Truvada
The drug is indicated as a combination treatment of HIV and for pre-exposure prophylaxis.
Generic HIV Drug Gets FDA Approval
FDA approves first generic version of emtricitabine and tenofovir disoproxil fumarate (Truvada).
Current Approaches to Treating HIV
There are few shortcuts that address the large number of medications and different treatment regimens that are needed to treat patients with HIV.
